Loading viewer...
investor_presentation
Format: PDF investor_presentation
Chimerix's corporate presentation outlines investment highlights and forward-looking statements regarding their clinical studies and market potential for ONC201 and ONC206.
investor_presentation
17 Pages
Cipher Pharmaceuticals
Sigma Additive Solutions SASI January 2023 Investor Presentation
investor_presentationinvestor_presentation
26 Pages
Sigma Additive Solutions, Inc.
AAC Technologies Holdings Investor Presentation — August 2021
investor_presentationinvestor_presentation
18 Pages
AAC Technologies Holdings Inc.
